✦ LIBER ✦

Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients

✍ Scribed by M. Carrasco; A. Sureda; C. Martínez; M. Carmona; A. Altés; G. Martín-Henao; A. Aventín; J. Sierra

Publisher: Springer
Year: 2002
Tongue: English
Weight: 186 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-002-0547-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic myelogenous leukemia in blast cr

Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients

✍ M. Griesshammer; B. Heinze; A. Hellmann; C. Popp; B. Anger; G. Heil; M. Bangerte 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 185 KB

Interferon alfa-2c in chronic myelogenou

Interferon alfa-2c in chronic myelogenous leukemia (CML): Hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma

✍ Herrmann, F. ;Jonas, D. ;Helfrich, S. G. ;Lindemann, A. ;Schleiermacher, E. ;Mer 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 849 KB

Molecular and cytogenetic characterizati

Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor–alpha genes in a patient with atypical chronic myeloid leukemia

✍ Anne Michele Safley; Siby Sebastian; Timothy S. Collins; Carlos A. Tirado; Timot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

## Abstract We report a case of __BCR‐ABL__‐negative atypical chronic myeloid leukemia (CML) with translocation t(4;22) (q12;q11.2) juxtaposing the breakpoint cluster region (__BCR__) and platelet‐derived growth factor receptor–alpha (__PDGFRA__) genes. The patient was a 57‐year‐old man with a hist